Statins for kidney disease patients: Protection for the heart but no effects on kidneys

Lowering LDL cholesterol through statin-based treatment did not slow kidney disease progression within five years in a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The results indicate that while LDL cholesterol-lowering therapy is safe in kidney disease patients and can reduce their risk of heart disease and stroke, it does not protect their kidney health as well.

Research has shown that lowering LDL cholesterol with statins can reduce patients' risk of experiencing heart attacks and strokes, but it's not clear whether it can also reduce the risk of , which requires dialysis or , in these patients.

To investigate, researchers conducted the Study of Heart and Renal Protection (SHARP), which included 6,245 nondialysis patients who were randomized to receive a placebo or cholesterol-lowering treatment with simvastatin (a statin) plus ezetimibe (a drug that inhibits the intestinal absorption of cholesterol).

Among the major findings after 5 years of follow-up:

  • Simvastatin plus ezetimibe lowered LDL cholesterol by an average of approximately 1 mmol/L (39 mg/dL) compared with placebo.
  • Simvastatin plus ezetimibe did not significantly reduce the need for dialysis or transplantation (33.9% cases vs 34.6% cases in the placebo group).
  • Treatment had no effect on the speed at which kidney function declined over time.

"The SHARP trial was the largest ever randomized trial in chronic kidney disease and previously showed that simvastatin plus ezetimibe did reduce the risk of heart attack, stroke, vascular stenting, or bypass surgery, but it did not affect the risk of end-stage renal disease," said first author Richard Haynes, MRCP (University of Oxford, UK). "Statins had no effect—neither good nor bad—on kidney function."

More information: The article, entitled "Effects of Lowering LDL Cholesterol on Progression of Kidney Disease," will appear online at jasn.asnjournals.org/ on May 1, 2014.

add to favorites email to friend print save as pdf

Related Stories

Cholesterol drug shows benefits for kidney patients

Nov 22, 2010

(PhysOrg.com) -- A combination drug that lowers levels of 'bad' cholesterol in the blood can benefit people with chronic kidney disease and is safe, a study led by the Clinical Trial Service Unit at Oxford University has ...

Heart drug 'safe for kidney patients'

Jun 13, 2011

(Medical Xpress) -- The full results of a trial show that people with chronic kidney disease can reduce their heart risk by taking a combination drug that lowers levels of ‘bad’ cholesterol.

Recommended for you

Researchers ferret out a flu clue

7 hours ago

Research that provides a new understanding as to why ferrets are similar to humans is set to have major implications for the development of novel drugs and treatment strategies.

11th Sierra Leonean doctor dies from Ebola

10 hours ago

One of Sierra Leone's most senior physicians died Thursday from Ebola, the 11th doctor in the country to succumb to the disease, a health official said.

In the battle against Ebola, a double-layer solution

10 hours ago

When working with Ebola patients, protective gear works, but removing it can be harrowing. Seeking to protect health care workers from the precarious nature of taking off soiled gloves, Cornell students have ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.